News from valeant pharmaceuticals international, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 25, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Announces The Addition Of D. Robert Hale To Its Board Of Directors

Jeffery W. Ubben Has Resigned From Board  Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the addition...

Aug 20, 2015, 07:28 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Acquire Sprout Pharmaceuticals

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Sprout Pharmaceuticals, Inc. today announced that they have entered into a...

Jul 23, 2015, 06:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Reports Second Quarter 2015 Financial Results

2015 Second Quarter Results - Total Revenue $2.7 billion; an increase of 34% over the prior year - Excluding negative impact of...

Jul 17, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has entered into a definitive agreement under...

Jun 24, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Announce 2015 Second Quarter Results On July 23, 2015

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet...

Jun 23, 2015, 09:15 ET
Valeant Pharmaceuticals International, Inc.

Valeant and Progenics Announce the Submission of U.S. New Drug Application for Oral RELISTOR®

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today...

Jun 11, 2015, 09:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Appoint Robert L. Rosiello As Chief Financial Officer

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that Robert L. Rosiello was appointed as Executive Vice...

May 27, 2015, 17:59 ET
Valeant Pharmaceuticals International, Inc.

Salix Announces FDA Approval of Xifaxan® 550 mg for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea)

Xifaxan® 550 mg is the first-and-only nonsystemic antibiotic approved for the treatment of IBS-D in adults  Valeant Pharmaceuticals...

May 19, 2015, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Announces 2015 Annual Meeting Results

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the election of eleven directors nominated at its 2015...

May 12, 2015, 16:05 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Webcast 2015 Annual Meeting Of Shareholders

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual...

Apr 29, 2015, 06:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Announces CFO Succession Plan And Additional Executive Appointment

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Howard B. Schiller has advised the Company of his decision...

Apr 29, 2015, 06:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Reports First Quarter 2015 Financial Results

2015 First Quarter Results - Total Revenue $2.2 billion; an increase of 16% over the prior year despite negative foreign exchange impact of...

Apr 24, 2015, 09:14 ET
Valeant Pharmaceuticals International, Inc.

RELISTOR® Receives Positive CHMP Opinion in the EU for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced...

Apr 09, 2015, 08:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals To Announce 2015 First Quarter Results On April 29, 2015

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast...

Apr 01, 2015, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019

Salix Pharmaceuticals, Ltd. (the "Company" or "Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX)...

Apr 01, 2015, 17:00 ET
Valeant Pharmaceuticals International, Inc.

Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015

 Salix Pharmaceuticals, Ltd. (the "Company" or "Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX)...

Apr 01, 2015, 09:05 ET
Valeant Pharmaceuticals International, Inc.

Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021

 Salix Pharmaceuticals, Ltd. ("Salix"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX:VRX), today...

Apr 01, 2015, 09:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Salix Pharmaceuticals

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the previously announced acquisition of Salix...

Apr 01, 2015, 06:00 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd.

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the expiration of the tender offer (the "Offer")...

Mar 27, 2015, 10:09 ET
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today the closing of its previously announced registered offering...